Clinical trial of brand-new Bionovo menopause drug moves forward Today.

Mary Tagliaferri. Dr. Tagliaferri is also the co-author of The New Menopause Book: PROFESSIONALS Help You Make Informed Decisions on HRT, Natural Hormone Therapy, Organic Therapies, Traditional Chinese Medication and more . The clinical trials will again be under the directorship of Dr. Grady, and will happen at four leading educational medical centers, including the University of California, SAN FRANCISCO BAY AREA; the University of Minnesota, Minneapolis; the University of Tennessee Health Science Middle, and the University of Alabama, Birmingham.Bionovo expects this Stage 2 trial to be completed by the second quarter of 2007. If commercialized, Bionovo’s focus on for MF101 is definitely in the multi-billion dollar menopausal market. ‘This is a critical area for drug development, since the WHI shows that the risks of hormone therapy outweigh the benefits.Ginseng is one of the very best recommended herbal remedies for treating nutrient insufficiency related lower body weight problems. You can make usage of ginseng milk early in the first morning and at night. For effective result, ensure that you follow a wholesome lifestyle with well balanced diet and frequent exercises. Those who desire to see exceptional result may use FitOFat capsule within their daily diet. When possible, make an effort to follow a diet plan schedule with adequate fruits and vegetables. Also, by no means hesitate to include items like shilajit in daily food diet. Also, do frequent exercises for at least 30 mins per day. When possible, continue using natural herbs like asparagus racemosus in diet plan.

Bristol-Myers Squibb last settlement with Securities and Exchange Commission Bristol-Myers Squibb has confirmed that it has reached a final settlement with the United States Securities and Exchange Commission , in April 2002 concluding an investigation concerning wholesaler inventory and accounting issues that began.